Realist evaluation of the role of the Universal Health Coverage Partnership in strengthening policy dialogue for health planning and financing: a protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
17 01 2019
Historique:
entrez: 21 2 2019
pubmed: 21 2 2019
medline: 16 1 2020
Statut: epublish

Résumé

In 2011, WHO, the European Union and Luxembourg entered into a collaborative agreement to support policy dialogue for health planning and financing; these were acknowledged as core areas in need of targeted support in countries' quest towards universal health coverage (UHC). Entitled 'Universal Health Coverage Partnership', this intervention is intended to strengthen countries' capacity to develop, negotiate, implement, monitor and evaluate robust and integrated national health policies oriented towards UHC. It is a complex intervention involving a multitude of actors working on a significant number of remarkably diverse activities in different countries. The researchers will conduct a realist evaluation to answer the following question: How, in what contexts, and triggering what mechanisms, does the Partnership support policy dialogue for health planning and financing towards UHC? A qualitative multiple case study will be undertaken in Togo, Liberia, Democratic Republic of Congo, Cape Verde, Burkina Faso and Niger. Three steps will be implemented: (1) formulating context-mechanism-outcome explanatory propositions to guide data collection, based on expert knowledge and theoretical literature; (2) collecting empirical data through semistructured interviews with key informants and observations of key events, and analysing data; (3) specifying the intervention theory. The primary target audiences are WHO and its partner countries; international and national stakeholders involved in or supporting policy dialogues in the health sector, especially in low-income countries; and researchers with interest in UHC, policy dialogue, evaluation research and/or realist evaluation.

Identifiants

pubmed: 30782678
pii: bmjopen-2018-022345
doi: 10.1136/bmjopen-2018-022345
pmc: PMC6340476
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e022345

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: ER and VR are funded as research consultants by the Department of Health Systems Governance and Financing of WHO. DR, OS, MD and DP are experts at WHO and involved within the Universal Health Coverage Partnership.

Références

BMC Health Serv Res. 2016 Jul 18;16 Suppl 4:214
pubmed: 27454450
BMC Health Serv Res. 2016 Jul 18;16 Suppl 4:222
pubmed: 27454448
Lancet. 2016 Jun 18;387(10037):2482-4
pubmed: 27086171
Health Promot Perspect. 2015 Jul 07;5(2):104-15
pubmed: 26290826
BMC Health Serv Res. 2016 Jul 18;16 Suppl 4:217
pubmed: 27454794
Milbank Q. 2001;79(2):179-205, III-IV
pubmed: 11439464
Health Policy Plan. 2000 Sep;15(3):239-46
pubmed: 11012397
Health Policy Plan. 2016 Apr;31(3):332-45
pubmed: 26210167
BMC Health Serv Res. 2016 Jul 18;16 Suppl 4:218
pubmed: 27454907
BMC Public Health. 2014 Dec 17;14:1287
pubmed: 25516355
Healthc Policy. 2012 Feb;7(3):73-84
pubmed: 23372582
Milbank Q. 2012 Jun;90(2):311-46
pubmed: 22709390
Implement Sci. 2015 Oct 30;10:153
pubmed: 26519291
Health Res Policy Syst. 2009 Dec 16;7 Suppl 1:S14
pubmed: 20018104
Health Promot Int. 2011 Dec;26(4):408-20
pubmed: 21330307
BMC Health Serv Res. 2016 Jul 18;16 Suppl 4:220
pubmed: 27454356

Auteurs

Emilie Robert (E)

Training and Research Transcultural Team, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Valery Ridde (V)

Centre Population et Développement, Paris, Île-de-France, France.
Institut de recherche en santé publique, Université de Montréal, Montreal, Quebec, Canada.

Dheepa Rajan (D)

Department of Health Systems Governance and Financing, World Health Organization, Geneva, Switzerland.

Omar Sam (O)

Inter-Country Support Team, World Health Organization, Ouagadougou, Burkina Faso.

Mamadou Dravé (M)

Country Office, World Health Organization, Lomé, Togo.

Denis Porignon (D)

Department of Health Systems Governance and Financing, World Health Organization, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH